[18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor

PHASE3RecruitingINTERVENTIONAL
Enrollment

152

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Parkinson DiseaseEssential Tremor
Interventions
DRUG

SPECT

\[123I\]-FP-CIT SPECT imaging procedure

DRUG

PET

\[18F\] LBT-999 PET imaging procedure

Trial Locations (16)

3100

RECRUITING

Hôpital Pierre Paul Riquet - Purpan (CHU), Toulouse

13005

RECRUITING

CHU La Timone, Marseille

21000

RECRUITING

CLCC Georges-François Leclerc C.G.F.L, Dijon

30029

RECRUITING

Centre Hospitalier Universitaire de Nîmes, Nîmes

33076

RECRUITING

CHU Bordeaux, Bordeaux

35000

RECRUITING

Centre Eugène Marquis / CHU Pontchaillou, Rennes

37044

RECRUITING

CHRU Hôpital Bretonneau, Tours

44093

RECRUITING

Hôpital Laennec (CHU Nantes), Nantes

59037

RECRUITING

Hôpital Roger Salengro (CHRU de Lille), Lille

63000

RECRUITING

Centre Jean PERRIN / Hôpital Gabriel Montpied (CHU), Clermont-Ferrand

67033

NOT_YET_RECRUITING

Institut de cancérologie Strasbourg Europe, Strasbourg

69500

RECRUITING

Hospices Civils de Lyon, Lyon

75013

RECRUITING

CHU La Pitié Salpêtrière, Paris

93000

NOT_YET_RECRUITING

Hôpital Avicenne, Bobigny

94010

RECRUITING

Hôpital Henri Mondor, Créteil

Unknown

RECRUITING

Hôpital Brabois / Hôpital Central (CHRU Nancy), Nancy

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zionexa

INDUSTRY

NCT04265209 - [18F] LBT-999 PET Compared to [123I]-FP/CIT SPECT to Distinguish Between Parkinson's Diseases and Essential Tremor | Biotech Hunter | Biotech Hunter